HighTower Advisors
GH icon

HighTower Advisors’s Guardant Health GH Stock Holding History

HighTower Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.36M Sell
22,390
-1,056
-5% -$115K ﹤0.01% 1467
2026
Q1 		$2.17M Sell
23,446
-4,930
-17% -$495K ﹤0.01% 1670
2025
Q4 		$2.9M Sell
28,376
-9,524
-25% -$852K ﹤0.01% 1482
2025
Q3 		$2.37M Sell
37,900
-217
-0.6% -$11.8K ﹤0.01% 1537
2025
Q2 		$1.98M Sell
38,117
-12,990
-25% -$580K ﹤0.01% 1571
2025
Q1 		$2.18M Buy
51,107
+469
+0.9% +$20.2K ﹤0.01% 1481
2024
Q4 		$1.55M Sell
50,638
-92
-0.2% -$2.59K ﹤0.01% 1676
2024
Q3 		$1.16M Buy
50,730
+272
+0.5% +$7.7K ﹤0.01% 1840
2024
Q2 		$1.46M Sell
50,458
-364
-0.7% -$8.48K ﹤0.01% 1629
2024
Q1 		$1.04M Sell
50,822
-29,879
-37% -$640K ﹤0.01% 1783
2023
Q4 		$2.18M Sell
80,701
-1,962
-2% -$51.5K ﹤0.01% 1389
2023
Q3 		$2.45M Sell
82,663
-1,453
-2% -$51.1K ﹤0.01% 1270
2023
Q2 		$3.01M Sell
84,116
-7,256
-8% -$208K 0.01% 1132
2023
Q1 		$2.14M Buy
91,372
+30,642
+50% +$875K ﹤0.01% 1244
2022
Q4 		$1.65M Sell
60,730
-4,422
-7% -$202K ﹤0.01% 1389
2022
Q3 		$3.51M Sell
65,152
-1,518
-2% -$77.9K 0.01% 952
2022
Q2 		$2.69M Sell
66,670
-2,781
-4% -$138K 0.01% 1089
2022
Q1 		$4.6M Sell
69,451
-1,504
-2% -$103K 0.01% 931
2021
Q4 		$7.1M Sell
70,955
-3,084
-4% -$319K 0.02% 742
2021
Q3 		$9.26M Buy
74,039
+4,413
+6% +$524K 0.02% 567
2021
Q2 		$8.64M Buy
69,626
+573
+0.8% +$77.1K 0.03% 576
2021
Q1 		$10.5M Sell
69,053
-3,505
-5% -$530K 0.03% 466
2020
Q4 		$9.35M Buy
72,558
+7,670
+12% +$883K 0.04% 389
2020
Q3 		$7.25M Buy
64,888
+2,836
+5% +$259K 0.04% 431
2020
Q2 		$5.03M Buy
62,052
+1,684
+3% +$136K 0.03% 510
2020
Q1 		$4.2M Sell
60,368
-5,235
-8% -$402K 0.03% 501
2019
Q4 		$5.13M Buy
65,603
+5,395
+9% +$389K 0.03% 534
2019
Q3 		$3.84M Buy
60,208
+2,855
+5% +$252K 0.02% 661
2019
Q2 		$4.95M Buy
+57,353
New +$4.38M 0.03% 548

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

HighTower Advisors's GH Position: Q2 2026 in Review

HighTower Advisors reduced its Guardant Health (GH) stake by 4.5% in Q2 2026, selling an estimated $115K and leaving 22,390 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1467.

HighTower Advisors first reported a position in GH in Q2 2019 and has held it in 29 quarters since. The position peaked at $10.5M in Q1 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • HighTower Advisors held 22,390 shares of Guardant Health worth $3.36M as of Q2 2026.
  • HighTower Advisors sold 1,056 Guardant Health shares in Q2 2026, an estimated $115K.
  • Guardant Health made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1467 holding.
  • HighTower Advisors first reported a position in Guardant Health in Q2 2019 and has held it in 29 quarters since.
  • HighTower Advisors's Guardant Health position peaked at $10.5M in Q1 2021.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.